Skip to main content

Table 2 Baseline characteristics of the patients

From: Outcomes after EVAR in females are similar to males

Features Unmatched cohort Matched cohort
Female patients (n = 26) Male patients (n = 223) p value Female patients (n = 26) Male patients (n = 26) p value
Age, years, median (IQR) 75 (68–83) 69 (65–74) 0.014 75 (68–83) 73 (69–77) 0.687
Diabetes mellitus 12 (46.2) 54 (24.2) 0.016 12 (46.2) 11 (42.3) 0.780
Hypertension 24 (92.3) 146 (65.5) 0.005 24 (92.3) 24 (92.3) 1.000
Hyperlipidemia 8 (30.8) 65 (29.1) 0.864 8 (30.8) 6 (23.1) 0.532
Pulmonary disease 10 (38.5) 73 (32.7) 0.558 10 (38.5) 8 (30.8%) 0.560
Renal insufficiency 0 26 (11.7) 0.087 0 2 (7.7%) 0.490
Peripheral vascular disease 1 (3.8) 21 (9.4) 0.485 1 (3.8) 2 (7.7%) 1.000
Coronary artery disease 5 (19.2) 108 (48.4) 0.005 5 (19.2) 4 (15.4%) 1.000
CABG 0 52 (23.3) 0.006 0 0
History of malignancy 0 14 (6.3) 0.373 0 0
Previous abdominal surgery 5 (19.2) 16 (7.2) 0.053 5 (19.2) 2 (7.7) 0.419
Body surface area, m2, mean ± SD 1.75 ± 0.24 1.88 ± 0.17 0.016 1.75 ± 0.24 1.85 ± 0.12 0.033
Aortic size index, mean ± SD 4.12 ± 0.84 3.47 ± 0.72 0.002 4.12 ± 0.84 3.67 ± 0.56 0.011
Maximum aneurysm diameter, mm, median (IQR) 62 (59–75) 60 (55–70) 0.273 62 (59–75) 63 (57–75) 0.953
Ejection fraction, % median (IQR) 55 (53–57) 55(48–58) 0.333 55 (53–57) 55 (52–60) 0.360